3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
3
Neoplasms
2
Agnosia
2
Recurrence
1
Pain, Postoperative
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplastic Cells, Circulating
1
Myofibroma
1
Melanoma
1
Liver Neoplasms
1
Leiomyoma
1
Delirium
1
Cancer Surgery
1
Interventions
Dexmedetomidine
12
Bupivacaine
11
Ropivacaine
8
Saline Solution
6
Morphine
6
Injections, Epidural
5
Ketamine
4
Control Groups
4
Acetaminophen
4
Sodium Chloride
3
Pregabalin
3
Dental Occlusion
3
Anesthesia, General
3
Analgesia, Patient-Controlled
3
parecoxib
2
Tea
2
Surgical Procedures, Operative
2
Parapsychology
2
Gabapentin
2
Anesthetics, Local
2
thiamine triphosphorate
1
tetraethylpyrazine
1
salicylhydroxamic acid
1
oxycodone-acetaminophen
1
esmolol
1
Vitamins
1
Transcutaneous Electric Nerve Stimulation
1
Thoracic Surgery, Video-Assisted
1
Therapeutics
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pain, Postoperative
×
Anesthesia, Spinal
×
Clear all
NCT03715517
2026-02-05
SAFER-L
University of Manitoba
Phase NA
Recruiting
128 enrolled